Hepatitis C: Screening assays;Hepatite C: Outils du depistage

Gastroenterologie Clinique et Biologique

Volumn 21, Issue 1 BIS, 1997, Pages

  Lunel, Françoise ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

ALT; chronic hepatitis; diagnosis; hepatitis C virus; polymerase chain reaction; risk factors; screening; serology

Indexed keywords

ALANINE AMINOTRANSFERASE; VIRUS RNA;

CHRONIC HEPATITIS; CONFERENCE PAPER; HEPATITIS C; HEPATITIS C VIRUS; POLYMERASE CHAIN REACTION; RISK FACTOR; RNA ANALYSIS; SCREENING TEST; VIRUS DETECTION;

EID: 0030946468     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (86)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359-62.
2. Houghton M, Weiner A, Han J, Kuo G, Choo QL. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology 1991;14:381-8.
3. Azar N, Valla D, Lunel F, Fretz C, Mallet A, Jaulmes D, et al. Post-transfusional anti-HCV-negative, non-A, non-B hepatitis. I. A prospective clinical and epidemiological survey. J Hepatol 1993;18:24-33.
4. Donahue JG, Munoz A, Ness PM, Brown DE, Yawn DH, Mc Allister HA, et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992;327:369-73.
5. Zuck TF. How should we test the tests ? Transfusion 1989;29:3-4.
6. Lunel F, Rosenheim M, Duneton P. Propositions pour une stratégie d'évaluation et d'utilisation des tests de dépistage de l'hépatite C. Transf Clin Biol 1996;5:279-88.
7. Zaaijer HL, Cuypers HTM, Reesink HW, Winkel IN, Gerken G, Lelie PN. Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet 1993;341:722-4.
8. Desenclos JC, Dubois F, Mariotte N, Goudeau A. Analyse des stratégies de dépistage orienté de l'infection par le virus de l'hépatite C. Gastroenterol Clin Biol 1997;21:S25-32.
9. Dienstag JL. Non A non B hepatitis. I. Recognition, epidemiology and clinical features. Gastroenterology 1983;85:439-62.
10. Busch MP, Korelitz JJ, Kleinman SH, Lee SR, Aubuchon JP, Schreiber GB, and the Retrovirus Epidemiology Donor Study. Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. Transfusion 1995;35:903-10.
11. Wolff C, Kleesiek K, Petersen N, Beyer J. Hepatitis C viremia in German blood donors: serum alanine aminotransferase is not a valid marker for screening. Transfusion 1994;34:361-2.
12. Kuo G, Choo QL, Alter HJ, Gitnik GL, Redeker AG, Purcell RH, et al. An assay for circulating antibodies to a major etiologic virus of human non-A non-B hepatitis. Science 1989;244:362-4.
13. Yuki N, Hayashi N, Hagiwara H, Takehara T, Oshita M, Kasahara A, et al. Serodiagnosis of chronic hepatitis C in Japan by second-generation recombinant immunoblot assay. J Hepatol 1993;17:170-4.
14. Couroucé AM. Les trousses de dépistage des anticorps anti-VHC: résultats comparatifs. Rev Fr Transf Hemobiol 1992;35:183-91.
15. Baath L, Widell A, Nordenfelt E. A comparison between one first generation and three second generation anti-HCV ELISAs: an investigation in high- and low-risk subjects in correlation with recombinant immunoblot assay and polymerase chain reaction. J Virol Methods 1992;40:287-96.
16. McHutchison JG, Person JL, Govindarajan S, Valinluck B, Gore T, Lee SR, et al. Improved detection of hepatitis C virus antibodies in high-risk populations. Hepatology 1992;15:19-25.
17. Aach RD, Stevens CE, Hollinger B, Mosley JW, Peterson DA, Taylor PE, et al. Hepatitis C virus infection in post-transfusion hepatitis. N Engl J Med 1991;325:1325-9.
18. Alter HJ, Purcell RH, Shin JW, Melpolder JC, Houghton M, Choo QL, et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989;321:1494-500.
19. Esteban JI, Gonzalez A, Hernandez JM, Viladomiu L, Sanchez C, Lopez-Talavera JC, et al. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. N Engl J Med 1990;323:1107-12.
20. Van der Poel CL, Bresters D, Reesink HW, Plaisier AAD, Schaasberg W, Leentvaar-Kuypers A, et al. Early antihepatitis C virus response with second-generation C200/C22 ELISA. Vox Sang 1992;62:208-12.
21. Vallari DS, Jett BW, Alter HJ, Mimms LT, Holzman R, Shin WK. Serological markers of posttransfusion hepatitis C viral infection. J Clin Microbiol 1992;30:552-6.
22. Giuberti T, Ferrari C, Marchelli S, Degli Antoni AM, Schianchi C, Pizzaferri P, et al. Long-term follow-up of anti-hepatitis C virus antibodies in patients with acute non-A non-B hepatitis and different outcome of liver disease. Liver 1992;12:94-9.
23. Couroucé AM, Le Marrec N, Girault A, Ducamp S, Simon N. Anti-hepatitis C virus (anti-HCV) seroconversion in patients undergoing hemodialysis: comparison of second- and third-generation anti-HCV assays. Transfusion 1994;34:790-5.
24. Alter HJ, Tegtmeier GE, Jett BW, Quan S, Shih JW, Bayer WL, et al. The use of a recombinant immunoblot assay in the interpretation of anti-hepatitis C virus reactivity among prospectively followed patients, implicated donors, and random donors. Transfusion 1991;31:771-6.
25. Ikeda Y, Toda G, Hashimoto N, Kurokawa K. Antibody to superoxide dismutase, autoimmune hepatitis and antibody tests for hepatitis C virus. Lancet 1990;335:1345-6.
26. Theilmann L, Blazek M, Goeser T, Gmelin K, Kommerell B, Fiehn W. False-positive anti-HCV tests in rheumatoid arthritis. Lancet 1990;335:1346.
27. McFarlane IG, Smith HN, Johnson PJ, Gray GP, Vergani D, Williams R. Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result ? Lancet 1990;335:754-7.
28. Boudart D, Lucas JC, Muller JY, Le Carrier D, Planchon B, Harousseau JL. False-positive hepatitis C virus antibody tests in paraproteinaemia. Lancet 1990;336:63.
29. Yuki N, Hayashi N, Hagiwara H, Naito M, Ohkawa K, Kasahara A, et al. Hepatitis C virus antibodies and virus replication in asymptomatic blood donors. Vox Sang 1994;67:280-5.
30. Bukh J, Wantzin P, Krogsgaard K, Knudsen F, Purcell RH, Miller RH. High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: failure of commercially available antibody tests to identify a significant number of patients with HCV infection. J Infect Dis 1993;168:1343-8.
31. Uyttendaele S, Claeys H, Mertens W, Verhaert H, Vermylen C. Evaluation of third-generation screening and confirmatory assays for HCV antibodies. Vox Sang 1994;66:122-9.
32. Lavanchy D, Mayerat C, Morel B, Schneider P, Zufferey C, Gonvers JJ, et al. Evaluation of third-generation assays for detection of anti-hepatitis C virus (HCV) antibodies and comparison with presence of HCV RNA in blood donors reactive to c100-3 antigen. J Clin Microbiol 1994;32:2272-5.
33. Van der Poel CL, Cuypers HTM, Reesink HW, Weiner AJ, Quan S, Di Nello R, et al. Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay Lancet 1991;337:317-9.
34. Watanabe J, Matsumoto C, Shimada T, Yoshizawa H, Okamoto H, Iizuka H, et al. Predictive value of screening tests for persistent hepatitis C virus infection evidenced by viremia. Vox Sang 1993;65:199-203.
35. Couroucé AM, Barin F, Botte C, Lunel F, Maisonneuve P, Maniez M, et al. A comparative evaluation of the sensitivity of seven anti-hepatitis C virus screening tests. Vox Sang 1995;69:213-6.
36. e Congrès de la Société Française de Microbiologie. Tours: Société Française de Microbiologie, mai 1985.
37. Lunel F, Frangeul L, Perrin M, Huraux JM. Diagnosis of acute HCV infection in immunosuppressed patients. Proceedings of the IXth Triennial Symposium on Viral Hepatitis and Liver Disease. Roma, 1996: 230.
38. Sato S, Fujiyama S, Tanaka M, Goto M, Taura Y, Kawano SI, et al. IgM and IgA antibodies generated against hepatitis C virus core antigen in patients with acute and chronic HCV infection. Dig Dis Sci 1994;39:2022-31.
39. Yuki N, Hayashi N, Hagiwara H, Naito M, Ohkawa K, Katayama K, et al. IgG and IgM core antibodies and viral replication in hepatitis C virus carriers. J Hepatol 1994;21:110-4.
40. Tassopoulos NC, Hatzakis AE, Papatheodoridis GV, Karvountzis G, Troonen H, Lennartz L. Early prediction of successful alpha-interferon therapy of chronic hepatitis C by core-IgM antibodies to hepatitis C virus. J Hepatol 1994;20:305-11.
41. Nagayama R, Miyake K, Tsuda F, Okamoto H. IgM antibody to a hepatitis C virus core peptide (CP14) for monitoring activity of liver disease in patients with acute or chronic hepatitis C. J Med Virol 1994;42:311-7.
42. Ebling F, Naukkarien R, Liikola J. Recombinant immunoblotting assay for hepatitis C virus as predictor of infectivity. Lancet 1990;335:982-3.
43. Bresters D, Zaaijer HL, Cuypers HTM, Reesink HW, Winkel IN, Van Exel-Oehlers PJ, et al. Recombinant immunoblot assay reaction patterns and hepatitis C virus RNA in blood donors and non-A, non-B hepatitis patients. Transfusion 1993;33:634-8.
44. Nakatsuji Y, Matsumoto A, Tanaka E, Ogata H, Kiyosawa K. Detection of chronic hepatitis C virus infection by four diagnostic systems: first-generation and second-generation enzyme-linked immunosorbent assay, second-generation recombinant immunoblot assay and nested polymerase chain reaction analysis. Hepatology 1992;16:300-5.
45. Chaudhary RK, McLean C. Evaluation of first- and second-generation RIBA kits for detection of antibody of hepatitis C virus. J Clin Microbiol 1991;29:2329-30.
46. Polito AJ, Di Nello RK, Quan S, Andrews W, Rose J, Lee F, et al. New generation RIBA hepatitis C strip immunoblot assays. Ann Biol Clin 1992;50:329-36.
47. Dussaix E, Charnaux N, Laurent-Puig P, Chopineau S, Laurian Y, Buffet C. Analysis of sera indeterminate by Ortho-HCV RIBA-2 by using three confirmatory assays for anti-hepatitis C virus antibody. J Clin Microbiol 1994;32:2071-5.
48. Rivanera D, Lorino G, Lilli D, Dicuonzo G, Mancini C. Evaluation of indeterminate sera for hepatitis C virus by assays using synthetic peptides. Eur J Epidemiol 1994;10:235-7.
49. Pawlotsky JM, Fleury A, Choukroun V, Deforges L, Roudot-Thoraval F, Aumont P, et al. Significance of highly positive c22-3 « indeterminate » second-generation hepatitis C virus (HCV) recombinant immunoblot assay (RIBA) and resolution by third-generation HCV RIBA. J Clin Microbiol 1994;32:1357-9.
50. Zanella A, Conte D, Prati D, Mozzi F, Capelli C, Zanuso F, el al. Hepatitis C virus RNA and liver histology in blood donors reactive to a single antigen by second-generation recombinant immunoblot assay. Hepatology 1995;21:913-7.
51. Lunel F, Perrin M, Frangeul L, Aumont P, Opolon P, Huraux JM. Sensitivity of third generation Ortho HCV ELISA and RIBA in 143 patients with indeterminate second generation. Proceedings of the 4th International Symposium of HCV Tokyo, may 1993;66:72.
52. Puoti M, Zonaro A, Ravaggi A, Marin MG, Castelnuovo F, Cariani E. Hepatitis C virus RNA and antibody response in the clinical course of acute hepatitis C virus infection. Hepatology 1992;16:877-81.
53. Lunel F, Cadranel JF, Perrin M, Grippon P, Desruenne M, Huraux JM, et al. Anti-hepatitisC virus (HCV) antibodies in heart transplant recipients with post-transplantation chronic viral B and non-A, non-B hepatitis. Dig Dis Sci 1991;36:124-5.
54. Frangeul L, Lunel F, Perrin M, Cresta P, Huraux JM. Relationship between serum hepatitis C virus (HCV) markers and response to interferon therapy. Proceedings of the IXth Triennial Symposium on Viral Hepatitis and Liver Disease. Roma, 1996;D253:341.
55. Buffet C, Charnaux N, Laurent-Puig P, Chopineau S, Quichon JP, Briantais MJ, et al Enhanced detection of antibodies to hepatitis C virus by use of a third-generation recombinant immunoblot assay. J Med Virol 1994;43:259-61.
56. Lamoril J, Lunel F, Laurent-Puig P, Defer C, Loiseau P, Lefrère JJ, et al. Indeterminate third-generation recombinant immunoblot assay in hepatitis C virus infection. J Hepatol 1994;21:133-4.
57. Azia I, De Medina M, Li XM, Poniachik J, Bartolomew M, Jeffers IJ, et al. Evaluation of RIBA HCV 2.0 SIA indeterminate specimens by RIBA HCV 3.0 SIA and HCV RNA by PCR (abstract). Hepatology 1994;20:240A.
58. Persing DH. Polymerase chain reaction: trenches to benches. J Clin Microbiol 1991;29:1281-5.
59. Garson JA, Ring C, Tuke P, Tedder RS. Enhanced detection by PCR of hepatitis C virus RNA. Lancet 1990;336:878-9.
60. Mantero G, Zonaro A, Albertini A, Bertolo P, Primi D. DNA enzyme immunoassay: general method for detecting products of polymerase chain reaction. Clin Chem 1991;37:422-9.
61. French Study Group for the Standardization of Hepatitis C Virus PCR. Improvement of hepatitis C virus RNA polymerase chain reaction through a multicentre quality control study. J Virol Methods 1994;49:79-88.
62. Young KKY, Resnick RM, Myers TW. Detection of hepatitis C virus RNA by a combined reverse transcription-polymerase chain reaction assay. J Clin Microbiol 1993;31:882-6.
63. Saldanha J, Minor P. Collaborative study to assess the suitability of an HCV RNA reference sample for detection of an HCV RNA in plasma pools by PCR. Vox Sang 1996;70:148-51.
64. Van Doom LJ, Kleter B, Voermans J, Maertens G, Brouwer H, Heijtink R, et al. Rapid detection of hepatitis C virus RNA by direct capture from blood. J Med Virol 1994;42:22-8.
65. Lunel F, Mariotti M, Cresta P, De La Croix I, Huraux JM, Lefrère JJ. Comparative study of conventional and novel strategies for the detection of hepatitis C virus RNA in serum: Amplicor, branched-DNA, NASBA and in-house PCR. J Virol Methods 1995;54:159-71.
66. Detmer J, Lagier R, Flynn J, Zayati C, Kolberg J, Collins M, et al. Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology. J Clin Microbiol 1996;34:901-7.
67. Hsuih TCH, Park YN, Zaretsky C, Wu F, Tyagi S, Russell-Kramer F, et al. Novel, ligation-dependent PCR assay for detection of hepatitis C virus in serum. J Clin Microbiol 1996;34:501-7.
68. Castillo I, Bartolome J, Quiroga JA, Carreno V. Comparison of several PCR procedures for detection of serum HCV-RNA using different regions of the HCV genome. J Virol Methods 1992;38:71-80.
69. Parvaz P, Guichard E, Chevallier P, Ritter J, Trépo C, Sepetjan M. Hepatitis C: description of a highly sensitive method for clinical detection of viral RNA. J Virol Methods 1994;47:83-94.
70. Bukh J, Purcell RH, Miller RH. Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay. Proc Natl Acad Sci USA 1992;89:187-91.
71. McGuinness PH, Bishop GA, Lien A, Wiley B, Parsons C, McGaughan GW. Detection of serum hepatitis C virus RNA in HCV antibody-seropositive volunteer blood donors. Hepatology 1993;18:485-90.
72. Ravaggi A, Zonaro A, Mazza C, Albertini A, Cariani E. Quantification of hepatitis C virus RNA by competitive amplification of RNA from denatured serum and hybridization on microtiter plates. J Clin Microbiol 1995;33:265-9.
73. Payan C, Cottin J, Lunel F. Validation of HCV RNA detection in serum by Amplicor compared to nested-PCR: a two-year follow-up (abstract). Hepatology 1996;24:385A.
74. Wang JT, Wang TH, Sheu JC, Lin SM, Lin JT, Chen DS. Effects of anticoagulants and storage of blood samples on efficacy of the polymerase chain reaction assay for hepatitis C virus. J Clin Microbiol 1992;30:750-3.
75. Halfon P, Khiri H, Gérolami V, Bourlière M, Féryn JM, Reynier P, et al. Impact of various handling and storage conditions on quantitative detection of hepatitis C virus RNA. J Hepatol 1996;25.307-11.
76. Payan C, Lunel F, and the Fontevraud Study Group. Appropriate conservation of sera (abstract), J Hepatol 1996;25 (suppl 1):116.
77. Davis GL, Lau JYN, Urdea MS, Neuwald PD, Wilber JC, Lindsay K, et al. Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: definition of optimal conditions for specimen collection and clinical application in interferon-treated patients. Hepatology 1994;19:1337-41.
78. Dubois F, Desenclos JC, Mariotte N, Goudeau A. Séroprévalence de l'infection par le virus de l'hépatite C dans un échantillon national d'assurés sociaux volontaires à un examen de santé de la Sécurité Sociale. Bull Epidemiol Hebdo 1996;5:17-9.
79. Shiell A, Briggs A, Farrell GC. The cost effectiveness of alpha Interferon in the treatment of chronic active hepatitis C. Med J Aust 1994;160:268-72.
80. Jullien AM. Suivi médical des donneurs de sang porteurs d'anticorps contre le virus de l'hépatite C. Intérêt pour les receveurs des enquêtes transfusionnelles. Gastroenterol Clin Biol 1996;20:657-60.
81. Bonaguidi-Magniaux M, Pilette C, Oberti F, Bidt ML, Calès P. Le suivi des donneurs de sang ayant une sérologie de l'hépatite C positive et de leurs receveurs est insuffisant. Gastroenterol Clin Biol 1996;20:663-8.
82. Schreiber GB, Busch M, Kleinman SH, Korelitz JJ, for the Retrovirus Epidemiology Donor Study. The risk of transfusion-transmitted viral infections. N Engl J Med 1996;334:1685-90.
83. Pillonel J, Saura C, Couroucé AM. Dépistage des marqueurs d'une infection par le VIH, l'HTLV et les virus des hépatites B et C chez les donneurs de sang en France. Bull Epidemiol Hebdo 1996;3:9-11.
84. Lok ASF, Chien D, Choo QL, Chan TM, Chiu KW, Cheng IKP, et al. Antibody response to core, envelope and nonstructural hepatitis C virus antigens: Comparison of immunocompetent and immunosuppressed patients. Hepatology 1993;18:497-502.
85. Lunel F, Fretz C, Perrin M, Cresta P, Boudifa A, Fournel JJ, et al. Prospective study of the discordances between two different ELISA for the detection of anti-HCV antibodies. Proceedings of the IXth triennial Symposium on Viral Hepatitis and Liver Disease. Roma, 1996;C180:249.
86. Dow BC, Follett EAC, Munro H, Buchanan I, Roy K, McOmish F, et al. Failure of 2nd- and 3rd-generation HCV ELISA and RIBA to detect HCV polymerase chain reaction-positive donations. Vox Sang 1994;67:236-7.